| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 4 | 0.582 | 0.692 | 2.0E-06 |
|
disease | 0.100 | None | 0.971 | 3 | 0 | 2002 | 2020 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 5 | 0.597 | 0.654 | 8.0E-07 |
|
disease | 0.100 | None | 0.962 | 4 | 0 | 2002 | 2020 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.100 | None | 0.944 | 1 | 0 | 2006 | 2020 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2005 | 2019 | ||||||||
|
asporin | 0.636 | 0.500 | 1.0E-07 |
|
disease | 0.400 | None | 0.931 | 4 | 0 | 2005 | 2019 | ||||||||
|
beta-2-microglobulin | 0.447 | 0.846 | 0.56 |
|
disease | 0.020 | None | 0.500 | 1 | 0 | 2002 | 2003 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
bone morphogenetic protein 5 | 0.653 | 0.577 | 9.0E-04 |
|
disease | 0.060 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
C-C motif chemokine ligand 11 | 0.473 | 0.885 | 1.0E-02 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2016 | ||||||||
|
C-C motif chemokine ligand 21 | 0.502 | 0.769 | 3.6E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
cellular communication network factor 6 | 0.568 | 0.731 | 6.2E-04 |
|
disease | 0.120 | None | 1.000 | 1 | 0 | 2004 | 2015 | ||||||||
|
CD247 molecule | 0.539 | 0.731 | 1.7E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
chromogranin A | 0.490 | 0.808 | 3.0E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
component of inhibitor of nuclear factor kappa B kinase complex | 0.556 | 0.731 | 0.99 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.200 | None | 0.900 | 1 | 0 | 1998 | 2018 | ||||||||
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
disease | 0.500 | None | 0.941 | 2 | 0 | 1993 | 2020 | ||||||||
|
cartilage oligomeric matrix protein | 0.503 | 0.808 | 1.3E-09 |
|
disease | 0.500 | None | 0.971 | 2 | 0 | 1995 | 2019 | ||||||||
|
crystallin alpha B | 0.515 | 0.731 | 2.2E-02 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.100 | None | 0.955 | 2 | 0 | 2002 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 13 | 0.472 | 0.731 | 0.83 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2001 | 2008 | ||||||||
|
cytochrome b-245 alpha chain | 0.520 | 0.769 | 8.9E-06 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2013 |